• Home
• morefeel brand
• Sanofi and GSK to seek authorization for COVID vaccine

Sanofi and GSK to seek authorization for COVID vaccine

4.8 (184) · $ 12.99 · In stock

Sanofi announces encouraging results for its booster against Omicron variant – Euractiv

Sanofi, GSK score late win with EU COVID booster approval

GSK's RSV vaccine Arexvy is effective in adults aged 50-59

EC grants approval for Sanofi-GSK's Covid-19 booster

Sanofi, GSK to seek regulatory approval for COVID vaccine

EU to receive 300 million COVID-19 vaccine doses from Sanofi and GSK

Recon: Sanofi, GSK to seek approval for COVID vaccine candidate; Novavax begins shipping vaccines to EU states

Sanofi/GSK COVID-19 Vaccine: What You Should Know

Sanofi, GSK to seek authorization for COVID-19 vaccine

Looking beyond COVID-19 vaccine phase 3 trials

EMA starts review of Sanofi-GSK COVID vaccine application

Global PPE (@Global_PPE_Inc) / X